ArticleClinical & translational immunology2021

Human neutralising antibodies elicited by SARS-CoV-2 non-D614G variants offer cross-protection against the SARS-CoV-2 D614G variant.

Cheryl Yi-Pin Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.